CIK 0001016504 · Non-accelerated filer<br>Smaller reporting company
INTEGRATED BIOPHARMA INC
Sign in to watch- Ticker
- INBP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222407475
- Phone
- 9739260816
- Business address
- 225 LONG AVENUE, BUILDING 15, HILLSIDE, NJ, 07205
- Former names
- INTEGRATED HEALTH TECHNOLOGIES INC, CHEM INTERNATIONAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 26 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-18 | FRIEDMAN ERIC J Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2023-07-18 | DeSantis Damon Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2023-05-30 | KAY CHRISTINA Co-Chief Executive Officer | Gift | +50,000 | $0.34 | $17K | 1,811,800 |
| 2023-05-30 | RIVA SHEPPARD Co-Chief Executive Officer | Gift | +50,000 | $0.34 | $17K | 1,811,800 |
| 2023-05-25 | KAY CHRISTINA Co-Chief Executive Officer | Grant or award | +3,410,512 | $0.40 | $1.4M | 3,410,512 |
| 2023-05-25 | KAY CHRISTINA Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-05-25 | KAY CHRISTINA Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +66,667 | 66,667 | ||
| 2023-05-25 | KAY CHRISTINA Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +21,667 | 21,667 | ||
| 2023-05-25 | RIVA SHEPPARD Co-Chief Executive Officer | Grant or award | +3,410,512 | $0.40 | $1.4M | 3,426,212 |
| 2023-05-25 | RIVA SHEPPARD Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-05-25 | RIVA SHEPPARD Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +66,667 | 66,667 | ||
| 2023-05-25 | RIVA SHEPPARD Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +21,667 | 21,667 | ||
| 2022-11-09 | Masi Dina Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-11-09 | KAY CHRISTINA Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-11-09 | RIVA SHEPPARD Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-11-09 | KAY E GERALD Executive Chairman & President | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-06-20 | Milmoe William H. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-06-20 | Canarick Robert Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-06-20 | DeSantis Damon Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-06-20 | FRIEDMAN ERIC J Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 |
Page 4 of 8 · 160 trades